Dysfunction of lung epithelial cells - a key component of the alveolar-capillary barrier - is central to the development of acute lung injury (ARDS). Cytokines, such as interleukin-1 (IL-1), oxidative stress and FasL are increased in lungs of ARDS patients but their relationship to each other and ARDS is unknown. The sources of oxidative stress in ARDS patients are also unknown but aldehyde oxidase (AOX) and xanthine oxidoreductase (XOR), which is increased in ARDS patients, are intracellular oxygen radical (O2*) generating enzymes whose regulation might be of benefit in ARDS. Our data shows that: 1. Leak and inflammation increased in lungs of rats given IL-1 intratracheally 5h before in vivo. 2. XOR expression, allopurinol-inhibitable 02* production, and apoptosis increased in epithelial cells in lungs of rats given IL-1 intratracheally 24h before in vivo. 3. Inhibition of lung XOR/AOX activity by tungsten feeding decreased epithelial cell apoptosis in lungs of rats given IL-1 intratracheally 24h before in vivo. 4. XOR/AOX expression and allopurinol-inhibitable 02* production, but not apoptosis, increased in lung epithelial cells treated with IL-1 24h before in vitro. 5. IL-1 and 02* increased lung epithelial cell Fas expression in vitro. 6. Lung lavage from rats given IL-1 intratracheally 24h before contained FasL and caused apoptosis of lung epithelial cells in vitro that had increased Fas levels following IL-1 treatment 24h before in vitro. 7. XOR and AOX gene expression was increased in lung epithelial cells treated with IL-1/IL-6 in vitro. Our specific hypothesis is that increased IL-1 increases XOR and/or AOX activity in lung epithelial cells increasing lung epithelial cell O2* production and Fas expression. Concomitant IL-1 dependent increases in lung inflammation increase lung FasL levels and produce epithelial cell apoptosis which contributes to lung injury CARDS).
Our specific aims are to determine the mechanisms responsible for IL-1 induced lung epithelial cell XOR and/or AOX expression, 02* production and epithelial cell apoptosis in vivo (Aim 1) and in vitro (Aim 2) and to determine the effect of IL-1 on the regulation of XOR and/or AOX gene expression in lung epithelial cells in vitro (Aim 3). The significance of this approach will be to determine basic physiologic, cellular and molecular aspects regarding XOR and AOX, to gain insight into whether XOR and/or AOX contribute to ARDS, and to evaluate whether inhibiting XOR and/or AOX holds any potential for treating or preventing events that contribute to ARDS.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL045582-10
Application #
6621351
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Harabin, Andrea L
Project Start
1992-02-10
Project End
2005-12-31
Budget Start
2003-01-01
Budget End
2003-12-31
Support Year
10
Fiscal Year
2003
Total Cost
$380,000
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Repine, John E; Elkins, Nancy D (2012) Effect of ergothioneine on acute lung injury and inflammation in cytokine insufflated rats. Prev Med 54 Suppl:S79-82
Gibbings, Sophie; Elkins, Nancy D; Fitzgerald, Hillary et al. (2011) Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-{gamma} sumoylation, and HIF-1{alpha}. J Biol Chem 286:961-75
Stupic, K F; Elkins, N D; Pavlovskaya, G E et al. (2011) Effects of pulmonary inhalation on hyperpolarized krypton-83 magnetic resonance T1 relaxation. Phys Med Biol 56:3731-48
Fini, Mehdi A; Monks, Jenifer; Farabaugh, Susan M et al. (2011) Contribution of xanthine oxidoreductase to mammary epithelial and breast cancer cell differentiation in part modulates inhibitor of differentiation-1. Mol Cancer Res 9:1242-54
Fini, Mehdi A; Orchard-Webb, David; Kosmider, Beata et al. (2008) Migratory activity of human breast cancer cells is modulated by differential expression of xanthine oxidoreductase. J Cell Biochem 105:1008-26
Roberts, Laura E; Fini, Mehdi A; Derkash, Noi et al. (2007) PD98059 enhanced insulin, cytokine, and growth factor activation of xanthine oxidoreductase in epithelial cells involves STAT3 and the glucocorticoid receptor. J Cell Biochem 101:1567-87
Seymour, Katherine J; Roberts, Laura E; Fini, Mehdi A et al. (2006) Stress activation of mammary epithelial cell xanthine oxidoreductase is mediated by p38 MAPK and CCAAT/enhancer-binding protein-beta. J Biol Chem 281:8545-58
Hybertson, Brooks M; Chung, Jin H; Fini, Mehdi A et al. (2005) Aerosol-administered alpha-tocopherol attenuates lung inflammation in rats given lipopolysaccharide intratracheally. Exp Lung Res 31:283-94
McManaman, James L; Palmer, Carol A; Anderson, Steven et al. (2004) Regulation of milk lipid formation and secretion in the mouse mammary gland. Adv Exp Med Biol 554:263-79
Yoon-yub, Park; Hybertson, Brooks; Wright, Richard et al. (2004) Serum ferritin elevation and acute lung injury in rats subjected to hemorrhage: reduction by mepacrine treatment. Exp Lung Res 30:571-84

Showing the most recent 10 out of 34 publications